The Competing Interests Statement contains information that is no longer accurate. The Competing Interests Statement should read: "Mohammed Kashani-Sabet owns stock in Melanoma Diagnostics, Inc., and James R. Miller III has ownership interest in MDMS, LLC. A patent application was filed regarding the patient-centered methodology described here. On the basis of prior work, patent applications were filed regarding the diagnostic and prognostic impact of the some of the markers described here, and were licensed to Myriad Genetics. This does not alter the authors' adherence to all of the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors."
Citation: Kashani-Sabet M, Sagebiel RW, Joensuu H, Miller JR III (2013) Correction: A Patient-Centered Methodology That Improves the Accuracy of Prognostic Predictions in Cancer. PLoS ONE 8(10): 10.1371/annotation/2db613f0-06cc-47e7-bde2-7c61bc792bb9. https://doi.org/10.1371/annotation/2db613f0-06cc-47e7-bde2-7c61bc792bb9
Published: October 21, 2013
Copyright: © 2013 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests: No competing interests declared.